Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series
International Journal of Infectious Diseases · 2024
DOI: 10.1016/j.ijid.2024.02.016 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Infectious Diseases, 2024. Verfasst von Lixue Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academ…. Hauptthemen laut MEDLINE: COVID-19, Lymphoma, Follicular, Lactams, Leucine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Although persistent or recurrent COVID-19 infection is well described in some immunosuppressed patient cohort, to date, there have been no reports of this phenomenon in the context of repeatedly negative SARS-CoV-2 testing in the upper respiratory tract. We reported six patients with follicular lymphoma who developed recurrent symptomatic COVID-19 infection. They tested persistently negative for SARS-CoV-2 on pharyngeal swabs and ultimately confirmed by bronchoalveolar lavage fluid metagenomics next-generation sequencing. All six patients presented with lymphopenia and B-cell depletion, and five of them received the anti-cluster of differentiation 20 treatment in the last year. Persistent fever was the most common symptom and bilateral ground-glass opacities were the primary pattern on chest computed tomography. A relatively long course of unnecessary and ineffective antibacterial and/or antifungal treatments was administered until the definitive diagnosis. Persistent fever subsided rapidly with nirmatrelvir/ritonavir treatment. Our case highlighted that recurrent COVID-19 infection should be suspected in immunocompromised patients with persistent fever despite negative pharyngeal swabs, and urgent bronchoalveolar lavage fluid testing is necessary. Treatment with nirmatrelvir/ritonavir appeared to be very effective in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, China.
- Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, China. Electronic address: liyanming263…
Zitieren
APA
Huang, L., Tong, X., Cui, J., Du, X., Liao, Y., Tan, X., Ju, Y., Zhong, X., Zhou, W., Xu, X., & Li, Y. (2024). Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2024.02.016
Vancouver
Huang L, Tong X, Cui J, Du X, Liao Y, Tan X, et al. Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series. International Journal of Infectious Diseases. 2024. doi:10.1016/j.ijid.2024.02.016
BibTeX
@article{Huang2024,
author = {Huang, Lixue and Tong, Xunliang and Cui, Jia and Du, Xiaoman and Liao, Yixuan and Tan, Xiaoming and Ju, Yang and Zhong, Xuefeng and Zhou, Wei and Xu, Xiaomao and Li, Yanming},
title = {Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series},
journal = {International Journal of Infectious Diseases},
year = {2024},
doi = {10.1016/j.ijid.2024.02.016}
}
EUVIMED